Scotia Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $72.3M | Buy |
147,090
+10,594
| +8% | +$5.75M | 0.3% | 62 |
|
|
2025
Q4 | $79.1M | Buy |
136,496
+7,962
| +6% | +$4.5M | 0.32% | 61 |
|
|
2025
Q3 | $62.3M | Buy |
128,534
+11,814
| +10% | +$5.5M | 0.27% | 67 |
|
|
2025
Q2 | $47.3M | Buy |
116,720
+29,180
| +33% | +$12.2M | 0.22% | 76 |
|
|
2025
Q1 | $43.6M | Buy |
87,540
+23,955
| +38% | +$13M | 0.23% | 72 |
|
|
2024
Q4 | $33.1M | Buy |
63,585
+23,168
| +57% | +$12.7M | 0.17% | 85 |
|
|
2024
Q3 | $25M | Buy |
40,417
+1,257
| +3% | +$744K | 0.13% | 99 |
|
|
2024
Q2 | $21.7M | Buy |
39,160
+849
| +2% | +$486K | 0.13% | 106 |
|
|
2024
Q1 | $22.3M | Buy |
38,311
+5,148
| +16% | +$2.89M | 0.13% | 105 |
|
|
2023
Q4 | $17.6M | Sell |
33,163
-1,519
| -4% | -$735K | 0.11% | 110 |
|
|
2023
Q3 | $17.6M | Sell |
34,682
-2,983
| -8% | -$1.59M | 0.13% | 109 |
|
|
2023
Q2 | $19.7M | Buy |
37,665
+4,401
| +13% | +$2.37M | 0.13% | 105 |
|
|
2023
Q1 | $19.2M | Buy |
33,264
+6,538
| +24% | +$3.68M | 0.14% | 103 |
|
|
2022
Q4 | $14.7M | Buy |
26,726
+263
| +1% | +$139K | 0.11% | 117 |
|
|
2022
Q3 | $13.4M | Buy |
26,463
+1,706
| +7% | +$955K | 0.11% | 120 |
|
|
2022
Q2 | $13.4M | Sell |
24,757
-166
| -0.7% | -$91.4K | 0.1% | 126 |
|
|
2022
Q1 | $14.7M | Buy |
24,923
+2,027
| +9% | +$1.16M | 0.09% | 129 |
|
|
2021
Q4 | $15.3M | Buy |
22,896
+9,074
| +66% | +$5.67M | 0.1% | 121 |
|
|
2021
Q3 | $7.9M | Sell |
13,822
-1,727
| -11% | -$948K | 0.06% | 193 |
|
|
2021
Q2 | $7.84M | Sell |
15,549
-1,250
| -7% | -$590K | 0.06% | 188 |
|
|
2021
Q1 | $7.67M | Sell |
16,799
-2,309
| -12% | -$1.1M | 0.06% | 175 |
|
|
2020
Q4 | $8.9M | Buy |
19,108
+4,144
| +28% | +$1.94M | 0.08% | 147 |
|
|
2020
Q3 | $6.61M | Buy |
14,964
+4,241
| +40% | +$1.75M | 0.07% | 156 |
|
|
2020
Q2 | $3.89M | Sell |
10,723
-3,190
| -23% | -$1.07M | 0.05% | 181 |
|
|
2020
Q1 | $3.95M | Buy |
13,913
+402
| +3% | +$127K | 0.06% | 174 |
|
|
2019
Q4 | $4.39M | Buy |
13,511
+1,070
| +9% | +$324K | 0.05% | 189 |
|
|
2019
Q3 | $3.62M | Buy |
12,441
+2,224
| +22% | +$637K | 0.04% | 206 |
|
|
2019
Q2 | $3M | Sell |
10,217
-1,766
| -15% | -$486K | 0.04% | 227 |
|
|
2019
Q1 | $3.28M | Sell |
11,983
-368
| -3% | -$91.6K | 0.04% | 210 |
|
|
2018
Q4 | $2.76M | Buy |
12,351
+96
| +0.8% | +$22.5K | 0.04% | 227 |
|
|
2018
Q3 | $2.99M | Buy |
12,255
+8,365
| +215% | +$1.92M | 0.04% | 240 |
|
|
2018
Q2 | $797K | Hold |
3,890
| – | – | 0.01% | 427 |
|
|
2018
Q1 | $803K | Buy |
3,890
+1,097
| +39% | +$230K | 0.01% | 441 |
|
|
2017
Q4 | $530K | Buy |
2,793
+20
| +0.7% | +$3.83K | 0.01% | 516 |
|
|
2017
Q3 | $525K | Sell |
2,773
-510
| -16% | -$92.4K | 0.01% | 502 |
|
|
2017
Q2 | $573K | Sell |
3,283
-89
| -3% | -$14.9K | 0.01% | 463 |
|
|
2017
Q1 | $518K | Sell |
3,372
-85
| -2% | -$13K | 0.01% | 517 |
|
|
2016
Q4 | $488K | Buy |
3,457
+593
| +21% | +$87.4K | 0.01% | 569 |
|
|
2016
Q3 | $456K | Sell |
2,864
-318
| -10% | -$49K | 0.01% | 585 |
|
|
2016
Q2 | $470K | Buy |
3,182
+833
| +35% | +$123K | 0.01% | 529 |
|
|
2016
Q1 | $333K | Buy |
+2,349
| New | +$315K | 0.01% | 541 |
|
|
2014
Q3 | – | Sell |
-3,484
| Closed | -$411K | – | 620 |
|
|
2014
Q2 | $411K | Buy |
+3,484
| New | +$410K | 0.01% | 442 |
|
Other funds holding TMO
VCM
Scotia Capital's TMO Position: Q1 2026 in Review
Scotia Capital increased its Thermo Fisher Scientific (TMO) stake by 7.8% in Q1 2026, buying an estimated $5.75M and bringing the position to 147,090 shares worth $72.3M. The position accounts for 0.3% of the portfolio, ranked #62.
Scotia Capital first reported a position in TMO in Q2 2014 and has held it in 42 quarters since. The position peaked at $79.1M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Scotia Capital held 147,090 shares of Thermo Fisher Scientific worth $72.3M as of Q1 2026.
- Scotia Capital bought 10,594 Thermo Fisher Scientific shares in Q1 2026, an estimated $5.75M.
- Thermo Fisher Scientific made up 0.3% of Scotia Capital's portfolio in Q1 2026, its #62 holding.
- Scotia Capital first reported a position in Thermo Fisher Scientific in Q2 2014 and has held it in 42 quarters since.
- Scotia Capital's Thermo Fisher Scientific position peaked at $79.1M in Q4 2025.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.